substance p has been researched along with sdz nkt 343 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, MC; Buchheit, KH; Campbell, EA; Docherty, R; Ewan, S; Hedley, L; James, IF; Ko, S; McIntyre, P; Urban, LA; Walpole, CS | 1 |
| Rees, H; Sluka, KA; Urban, L; Walpole, CJ; Willis, WD | 1 |
2 other study(ies) available for substance p and sdz nkt 343
| Article | Year |
|---|---|
Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Topics: Animals; Base Sequence; Binding Sites; Cell Line; COS Cells; DNA Primers; Ganglia, Spinal; Gerbillinae; Guinea Pigs; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Neurokinin-1 Receptor Antagonists; Proline; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Recombinant Proteins; Substance P | 1998 |
The effects of SDZ NKT 343, a potent NK1 receptor antagonist, on cutaneous responses of primate spinothalamic tract neurones sensitized by intradermal capsaicin injection.
Topics: Action Potentials; Animals; Capsaicin; Electrophysiology; Haplorhini; Injections, Intradermal; Male; Naphthalenes; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Neurons, Afferent; Proline; Skin; Spinothalamic Tracts; Substance P | 1998 |